Ascendis Pharma A (ASND) Current Taxes (2012 - 2026)

Ascendis Pharma A has reported Current Taxes for 13 years, with the latest figure at $9.1 million in Q1 2026.

• Quarterly Current Taxes rose 452.25% year-over-year to $9.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.1 million (up 452.25% YoY) and the FY2025 annual result came in at $7.5 million, up 472.92% from the prior year.
• Current Taxes rose to $9.1 million in Q1 2026 per ASND's latest filing, from $7.5 million in the prior quarter.
• Over five years, Current Taxes peaked at $9.1 million in Q1 2026 and troughed at $96035.1 in Q2 2022.
• A 5-year average of $3.4 million and a median of $1.9 million in 2025 frame the typical range for Current Taxes.
• The sharpest annual moves came in 2023 and 2024: Current Taxes soared 6445.9% in 2023, then sank 84.18% in 2024.
• Over 5 years, Current Taxes stood at $5.6 million in 2022, then plunged by 55.84% to $2.5 million in 2023, then sank by 47.21% to $1.3 million in 2024, then jumped by 472.92% to $7.5 million in 2025, then increased by 22.14% to $9.1 million in 2026.
• According to Business Quant data, Current Taxes over the past three periods registered $9.1 million, $7.5 million, and $1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.